SCHEMBL30832007

SCHEMBL30832007

COCc1ccc(CNC(=O)N(C)CC2CCNCC2)nc1

nearest known ligand 0.38

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 15/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ USP30 Q70CQ3 1/20 0.36
▸ NAMPT P43490 2/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ HTR2B P41595 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL29207944 0.94 HTR2A (0.39) HTR2AUSP30CYP1A2HTR2CCYP2C19
SCHEMBL29208108 0.92 HTR2A (0.40) HTR2AALDH1A1SMN1; SMN2USP30CYP1A2
Trifluoroacetic Acid SCHEMBL29208063 0.86 HTR2A (0.41) HTR2AALDH1A1SMN1; SMN2CYP1A2HTR2C
SCHEMBL30832028 0.83 USP30 (0.38) HTR2AALDH1A1SMN1; SMN2USP30
SCHEMBL29208052 0.83 USP30 (0.38) HTR2AALDH1A1SMN1; SMN2USP30
SCHEMBL29208060 0.80 BRD4 (0.38) HTR2AALDH1A1SMN1; SMN2
SCHEMBL30842023 0.79 HTR2A (0.41) HTR2ACYP1A2HTR2CCYP2C19HTR2B
Trifluoroacetic Acid SCHEMBL29208070 0.78 HRH4 (0.38) USP30
SCHEMBL29207994 0.77 ALDH1A1 (0.62) HTR2AALDH1A1SMN1; SMN2
SCHEMBL29208075 0.74 USP30 (0.49) ALDH1A1SMN1; SMN2USP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117964547-A Urea compound and application thereof as Sigma2 and 5HT2A dual-target inhibitor 瀚远医药有限公司 2024-05-03 — — CN disclosed
WO-2024067304-A1 COMPOUND WITH INHIBITORY ACTIVITY AGAINST SIGMA2 AND 5HT2A AND USE 瀚远医药有限公司 2024-04-04 — — WO disclosed
Send feedback